rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Carey Ng

Director

Company insider

Files Form 4 as: Director, Immix Biopharma.

In numbers

Trades disclosed
15
Buys
3
Sells
0
Bought
$169K
Sold
$0
Companies
1
Companies where not an officer
1
First trade
20 Dec 2021
Last trade
22 May 2026
Last filed
29 May 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
IMMX Immix BiopharmaDirector · Biotechnology · last 22 May 20263 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
22 May 2026filed 29 May 2026IMMX Immix BiopharmaBiotechnologySEC FORM 4 Code A—6,250 at $0.00filing
22 May 2026filed 29 May 2026IMMX Immix Biopharmaoption or derivative · BiotechnologySEC FORM 4 Code A—12,500 at $0.00filing
22 May 2026filed 29 May 2026IMMX Immix Biopharmaoption or derivative · BiotechnologySEC FORM 4 Code A—12,500 at $0.00filing
22 May 2026filed 29 May 2026IMMX Immix BiopharmaBiotechnologySEC FORM 4 Code A—6,250 at $0.00filing
20 Jun 2025filed 23 Jun 2025IMMX Immix Biopharmaoption or derivative · BiotechnologySEC FORM 4 Code A—33,000 at $0.00filing
16 Aug 2024filed 19 Aug 2024IMMX Immix BiopharmaBiotechnologySEC FORM 4 Bought$19K10,000 at $1.86filing
11 Jun 2024filed 21 Jun 2024IMMX Immix Biopharmaoption or derivative · BiotechnologySEC FORM 4 Code A—33,000 at $0.00filing
15 May 2024filed 20 May 2024IMMX Immix Biopharmaoption or derivative · BiotechnologySEC FORM 4 Code A—21,587 at $0.00filing
15 May 2024filed 20 May 2024IMMX Immix Biopharmaoption or derivative · BiotechnologySEC FORM 4 Code A—25,512 at $0.00filing
14 Sep 2023filed 15 Sep 2023IMMX Immix BiopharmaBiotechnologySEC FORM 4 Bought$26K10,000 at $2.58filing
11 Aug 2023filed 14 Aug 2023IMMX Immix Biopharmaoption or derivative · BiotechnologySEC FORM 4 Code A—20,000 at $0.00filing
14 Jul 2022filed 18 Jul 2022IMMX Immix Biopharmaoption or derivative · BiotechnologySEC FORM 4 Code A—16,000 at $0.00filing
20 Dec 2021filed 20 Dec 2021IMMX Immix Biopharmaoption or derivative · BiotechnologySEC FORM 4 Code C—filing
20 Dec 2021filed 20 Dec 2021IMMX Immix BiopharmaBiotechnologySEC FORM 4 Code C$850K1,000,221 at $0.85filing
20 Dec 2021filed 20 Dec 2021IMMX Immix BiopharmaBiotechnologySEC FORM 4 Bought$125K25,000 at $5.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care3

Buys in green, sells in red, by the company’s sector.

Related people

Nancy T. ChangDirector and 10% owner · Director at Immix Biopharma, filing Form 4 there in the last year
Jane BuchanDirector · Director at Immix Biopharma, filing Form 4 there in the last year
Helen C. AdamsDirector · Director at Immix Biopharma, filing Form 4 there in the last year
Magda MarquetDirector · Director at Immix Biopharma, filing Form 4 there in the last year
Ilya M. RachmanCEO and Chairman · CEO and Chairman at Immix Biopharma, filing Form 4 there in the last year